Association Between Aspirin Usage and Age-Related Macular Degeneration: An Updated Systematic Review and Meta-analysis

Association Between Aspirin Usage and Age-Related Macular Degeneration: An Updated Systematic Review and Meta-analysis

Purpose: To investigate the association between long-term use of aspirin and age-related macular degeneration (AMD).Methods: An updated systematic literature search was conducted in PubMed, Medline, Cochrane Library, and embase from conception to February 26, 2021, without any language restriction....

Full description

Bibliographic Details
Main Authors:	Ruijia Yan, Jing Zhao, Xinai Zhang, Wei Wang, Zhengyao Jiang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-03-01
Series:	Frontiers in Pharmacology
Subjects:	long-term use aspirin association age-related macular degeneration meta-analysis
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2022.824745/full

Similar Items

Baseline characteristics and age-related macular degeneration in participants of the “ASPirin in Reducing Events in the Elderly” (ASPREE)-AMD trial
by: Liubov D. Robman, et al.
Published: (2020-12-01)

Age-related macular degeneration in a randomized controlled trial of low-dose aspirin: Rationale and study design of the ASPREE-AMD study
by: Liubov Robman, et al.
Published: (2017-06-01)

Long-term outcomes of Ranibizumab treatment in neovascular age-related macular degeneration
by: Burak Simsek, et al.
Published: (2018-02-01)

Roles and mechanisms of long non-coding RNAs in age-related macular degeneration
by: Rong Zhang, et al.
Published: (2023-11-01)

Association between sunlight exposure and risk of age-related macular degeneration: a meta-analysis
by: Hongjie Zhou, et al.
Published: (2018-12-01)

Systemic Dyslipidemia in Age-related Macular Degeneration
by: Brandon Li, et al.
Published: (2024-01-01)

ASCEND-Eye: Rationale, design and baseline characteristics for a sub-study of the ASCEND randomised trial, exploring the effects of aspirin and omega-3 fatty acids on diabetic retinopathy and age-related macular degeneration
by: Emily Sammons, et al.
Published: (2023-10-01)

Geneticpolymorphism of SERPING1 rs2511989 and age-related macular degeneration: a Meta-analysis
by: Yu Qin, et al.
Published: (2015-06-01)

Treatment for exudative age-related macular degeneration with Conbercept: a Meta-analysis
by: Chun-Xing Li, et al.
Published: (2018-06-01)

Systemic Complement Activation Profiles in Nonexudative Age-Related Macular Degeneration: A Meta-Analysis
by: Jonathan B. Lin, et al.
Published: (2022-04-01)

Real-world outcomes of intravitreal antivascular endothelial growth factors for neovascular age-related macular degeneration in Taiwan: A 4-year longitudinal study
by: Benjamin Chi-Lan Yang, et al.
Published: (2019-01-01)

Neuroprotection for Age-Related Macular Degeneration
by: Jonathan B. Lin, MD, PhD, et al.
Published: (2022-12-01)

Comparison of efficacy between Ranibizumab and Conbercept for wet age-related macular degeneration
by: Qiang Fan, et al.
Published: (2018-08-01)

Acquired Vitelliform Macular Degeneration: Characteristics and Challenges of Managing Subretinal Fluid
by: Joseph Juliano, et al.
Published: (2021-10-01)

The Efficacy And Safety Of Aspirin As The Primary Prevention Of Cardiovascular Disease: An Updated Meta-Analysis
by: Xie W, et al.
Published: (2019-09-01)

Managing Neovascular Age-Related Macular Degeneration in Clinical Practice: Systematic Review, Meta-Analysis, and Meta-Regression
by: Daniele Veritti, et al.
Published: (2022-01-01)

Association between non-steroidal anti-inflammatory drug use and development of age-related macular degeneration—A 10-year retrospective cohort study
by: Tsung-Mu Yang, et al.
Published: (2024-04-01)

The Association between the Lipids Levels in Blood and Risk of Age-Related Macular Degeneration
by: Yafeng Wang, et al.
Published: (2016-10-01)

Aspirin Use on Incident Dementia and Mild Cognitive Decline: A Systematic Review and Meta-Analysis
by: Hui Li, et al.
Published: (2021-02-01)

Smoking,serum antioxidant vitamin levels and age-related macular degeneration
by: Sezen Akkaya Çakir, et al.
Published: (2014-05-01)

Rethinking the potential and necessity of drug delivery systems in neovascular age-related macular degeneration therapy
by: Xi Huang, et al.
Published: (2023-05-01)

Lower cognitive function in patients with age-related macular degeneration: a meta-analysis
by: Zhou LX, et al.
Published: (2016-02-01)

Association between SERPING1 rs2511989 polymorphism and age-related macular degeneration: Meta-analysis
by: Yi Dong, et al.
Published: (2015-04-01)

Association between genetic variation of complement C3 and the susceptibility to advanced age-related macular degeneration: a meta-analysis
by: Jun Zhang, et al.
Published: (2018-10-01)

Possible Association of Periodontal Disease and Macular Degeneration: A Case-Control Study
by: Federica Di Spirito, et al.
Published: (2020-12-01)

Combination of ranibizumab with photodynamic therapy vs ranibizumab monotherapy in the treatment of age-related macular degeneration:a systematic review and meta-analysis of randomized controlled trials
by: Jun-Kang Si, et al.
Published: (2014-06-01)

Biomarkers of macular neovascularisation activity using optical coherence tomography angiography in treated stable neovascular age related macular degeneration
by: Daren Hanumunthadu, et al.
Published: (2023-02-01)

NORMAL FLUENCE PHOTODYNAMIC THERAPY ASSOCIATED WITH LAMELLAR MACULAR HOLES IN EXUDATIVE AGE RELATED MACULAR DEGENERATION
by: Alvaro Rodriguez, et al.
Published: (2014-09-01)

Beyond the Complement Cascade: Insights into Systemic Immunosenescence and Inflammaging in Age-Related Macular Degeneration and Current Barriers to Treatment
by: Adnan H. Khan, et al.
Published: (2023-06-01)

Implantation of the First IMT Macular Lens in Age-Related Macular Degeneration (Literature Review)
by: M. M. Bikbov, et al.
Published: (2019-08-01)

Characterizing Macular Neovascularization in Myopic Macular Degeneration and Age-Related Macular Degeneration Using Swept Source OCTA
by: Sayah DN, et al.
Published: (2023-12-01)

Dry age-related macular degeneration - therapeutic possibilities and research directions
by: Alicja Zajdel
Published: (2022-10-01)

Association of Apolipoprotein E Alleles with Susceptibility to Age-Related Macular Degeneration in Iranian Patients
by: Mohammad Askari, et al.
Published: (2015-04-01)

Evaluation of serum interferons in patients with age-related macular degeneration
by: Mehrdad Afarid, et al.
Published: (2019-01-01)

Full-thickness macular hole formation following anti-VEGF injections for neovascular age-related macular degeneration
by: Kabanarou SA, et al.
Published: (2017-05-01)

Prevalence and genetic analyses of selected age-related macular degeneration-related polymorphisms and their responses to intravitreal ranibizumab
by: Mohamad, Nur Afiqah
Published: (2018)

Comparison of bevacizumab and ranibizumab in age-related macular degeneration:a systematic review and meta-analysis
by: Xiao-Yu Zhang, et al.
Published: (2014-04-01)

Intravitreal aflibercept in neovascular age-related macular degeneration previously treated with ranibizumab
by: Rachel Hui Fen Lim, et al.
Published: (2017-03-01)

Could aspirin be a lifesaver for prostate cancer patients in prostate cancer-specific mortality?: an update systematic review and meta-analysis
by: Jiatong Zhou, et al.
Published: (2019-12-01)

Diurnal variation of optical coherence tomography–based macular fluid in exudative age-related macular degeneration
by: Blake H. Fortes, et al.
Published: (2023-09-01)